Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

PCSK9 inhibitors

- PMLiVE

Amgen leukaemia drug gets FDA priority review

Adds to breakthrough status for blinatumomab

- PMLiVE

Amgen biosimilar matches AbbVie’s Humira in psoriasis trial

ABP 501 set to compete with world’s biggest-selling drug

- PMLiVE

Sanofi alerts US authorities over bribery allegations

Concerns raised by anonymous whistleblower

Sanofi reception

Trial suggests Sanofi’s asthma drug works in sinusitis

Dupilumab able to reduce polyp size in sinusitis patients

China flag thumb

Sanofi opens new Shanghai R&D headquarters

China-based hub for Asia Pacific will create 1,400 jobs

Sanofi reception

Sanofi provides bursaries to UK patient groups

Older People's Advocacy Alliance receives gold award of £25,000

- PMLiVE

Amgen files breakthrough leukaemia antibody in US

Already received top status from the FDA for the treatment of ALL

Sanofi reception

Sanofi licenses cardiomyopathy programme in $200m deal

Has rights to three of MyoKardia’s programmes

- PMLiVE

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

EU flag

Lantus faces first biosimilar rival in Europe

Sanofi prepares for insulin challenge from Boehringer and Lilly

- PMLiVE

Sanofi launches diabetes gaming app for children

Mission T1D aims to encourage discussion about how to live with the condition

dengue fever mosquito

Sanofi: positive trial sets up dengue vaccine filings

Could help prevent mosquito-borne fever that is endemic in Latin America and Asia

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links